Back
Travere Therapeutics Stock Price Chart
MarketBeat Alert: Escape the market madness with 7 stocks to buy and hold
The result is a select group of high-quality blue-chip stocks.
Sell
29
TVTX
Travere Therapeutics
Last Price:
6.2600
Seasonality Move:
-0.72%
7 Day Trial
ALL ACCESS PASS
$
7
20 Most Hated Stocks on Wall Street
Click here to see the full list and protect yourself before it's too late.- The current trend is relatively stagnant and TVTX is experiencing selling pressure, which indicates risk of future bearish movement.
Travere Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.69 | Buy |
| 20-day SMA: | 6.03 | Buy |
| 50-day SMA: | 7.07 | Sell |
| 200-day SMA: | 9.17 | Sell |
| 8-day EMA: | 5.89 | Buy |
| 20-day EMA: | 6.11 | Buy |
| 50-day EMA: | 6.84 | Sell |
| 200-day EMA: | 9.69 | Sell |
Travere Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.36 | Sell |
| Relative Strength Index (14 RSI): | 48.85 | Sell |
| Chaikin Money Flow: | -444096 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (5.6268 - 6.8468) | Buy |
| Bollinger Bands (100): | (6.7859 - 9.1059) | Sell |
Travere Therapeutics Technical Analysis
| Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Travere Therapeutics Stock
Is Travere Therapeutics Stock a Buy?
- Travere Therapeutics share price is 6.2600 while TVTX 8-day simple moving average is 5.6850, which is a Buy signal.
- The stock price of TVTX is 6.2600 while Travere Therapeutics 20-day SMA is 6.0300, which makes it a Buy.
- Travere Therapeutics 50-day simple moving average is 7.0712 while TVTX share price is 6.2600, making it a Sell technically.
- TVTX stock price is 6.2600 and Travere Therapeutics 200-day simple moving average is 9.1660, creating a Sell signal.
TVTX Technical Analysis vs Fundamental Analysis
Sell
29
Travere Therapeutics (TVTX)
is a Sell
Is Travere Therapeutics a Buy or a Sell?
-
Travere Therapeutics stock is rated a Sell
The current Travere Therapeutics [TVTX] share price is $6.2600. The Score for TVTX is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
Travere Therapeutics Stock Info
Market Cap:
476.38M
Price in USD:
6.2600
Share Volume:
767.08K
Travere Therapeutics 52-Week Range
52-Week High:
19.5424
52-Week Low:
5.1200
Sell
29
Travere Therapeutics (TVTX)
is a Sell
Travere Therapeutics Share Price Forecast
-
What is the Travere Therapeutics stock price today?
The Travere Therapeutics stock price is 6.2600 USD today. -
Will TVTX stock go up or go down?
Travere Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Travere Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Travere Therapeutics is overvalued.
Is Travere Therapeutics Stock a Buy?
- Travere Therapeutics share price is 6.2600 while TVTX 8-day exponential moving average is 5.8937, which is a Buy signal.
- The stock price of TVTX is 6.2600 while Travere Therapeutics 20-day EMA is 6.1135, which makes it a Buy.
- Travere Therapeutics 50-day exponential moving average is 6.8387 while TVTX share price is 6.2600, making it a Sell technically.
- TVTX stock price is 6.2600 and Travere Therapeutics 200-day simple moving average is 9.6858, creating a Sell signal.
Fundamental Analysis of Travere Therapeutics
Is Travere Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.56 per share, an increase next quarter of $0.07 per share, a decrease this year of $1.65 per share, and an increase next year of $1.32 per share.
Technical Analysis of Travere Therapeutics
Should I short Travere Therapeutics stock?
- TVTX Moving Average Covergence Divergence (MACD) indicator is -0.37, suggesting Travere Therapeutics is a Sell
- Travere Therapeutics Relative Strength Index (RSI) is 48.85, which suggest Travere Therapeutics is oversold
- The Bollinger Bands (25) for Travere Therapeutics is (5.6268 - 6.8468), which suggest Travere Therapeutics is a Sell
- The Bollinger Bands (100) for Travere Therapeutics is (6.7859 - 9.1059), which suggest Travere Therapeutics is a Sell
* Travere Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.